GammaDelta Therapeutics

GammaDelta Therapeutics is dedicated to leveraging the unique properties of γδ T cells to improve outcomes and survival rates for patients with hematologic malignancies and solid tumors. Our mission is to deliver highly effective allogeneic immunotherapies based on the distinct characteristics of Vδ1+ T cells, providing additional survival benefits to cancer patients. Our proprietary isolation and expansion protocols enable the selective generation of Vδ1+ T cell populations suitable for clinical applications.